At #KCRS25, we asked: Who here has received Department of Defense CDMRP funding or participated in a program supported by it?
This is who stood.
These researchers are the engine behind breakthroughs in #KidneyCancer. Their work has saved lives, improved treatments, and brought hope to patients and families across the country.
We can’t afford to lose this momentum. It’s time to #RestoreTheResearch.
Learn more and get involved: https://t.co/Faq7uPCDxB
#AcceleratingCures
Look at some of the impact of DOD CDMRP funding. @BraunMDPhD is presenting the personalized vaccine in RCC published in @Nature.
Please restore funding. It went from $50 Million to $0 Dollars. We have not solved cancer yet!
@kidneycan#KCRS25
Makary: FDA to look into further consolidating operations https://t.co/N10V5HVvvy
Seems like a bad idea considering the FDA is missing approval deadlines: FDA to miss approval deadline for Kalvista drug due to ‘resource constraints’
https://t.co/Id0CzqIxot
NEW: In the months since President Donald Trump returned to the White House, American doctors have shown skyrocketing interest in moving to Canada, where dozens more than normal have already been cleared to practice.
@BrettKelman reports. ⤵️ https://t.co/rOYaEoi0jS
📣Vote-A-Rama this pm in the Senate! This is a reminder that the MS Research Program & many CDMRP programs were zeroed out in FY25 in the CR. We owe our Vets answers about their service-connected illnesses. VOTE FOR AMENDMENT TO RESTORE CDMRP FUNDING! MS Activists tag your Sens.
NIH funding cuts could cost the U.S. $16 Billion and 68,000 jobs. An interactive tool from @joshuasweitz and team shows the local impact across the U.S. - down to the county level. This isn’t abstract - these numbers affect real communities and real lives: https://t.co/2gPVnVwaLU
Our NIH grant to discover coronavirus antiviral meds was terminated today.
With this grant, we had developed a better SARSCoV2 inhibitor than Paxlovid, and we recently discovered an improved drug that looks better than Pfizer's own second-generation inhibitor.